Shai Arbel, CEO of Terrogence Global, provides a valuable update on CBRN terrorism with the aim of raising awareness and helping first responders and...
By BG (ret.) William King
Science and technology during the Cold War limited the United States and Soviet Union Chemical and Biological Weapons (CBW) programs...
Are We Ready?
By Dr. Mary Sproull, Research scientist, National Cancer Institute - National Institutes of Health, USA.
Since the events of 9/11, we have come...
…and no, it is not what you are thinking
By Mr. Luca Romano, Founder and Mr. Fulvio Buzzi, Vice-admin, L'Avvocato dell'Atomo, Italy.
Luca Romano and Fulvio...
By COL Paul Kassebaum, Commander, U.S. Army Medical Research Institute of Chemical Defense (MRICD), and Dr. James Dillman, Chief Science Officer, MRICD, USA.
The U.S....
Interview with Dr. Antonella Cavallo, rescEU CBRN Lead at EU Commission DG ECHO, the European Commission's Department for Civil Protection and Humanitarian Aid Operations
Dr....
By Aktiv Pharma Group.
Automatic self-injection devices used for administering first-line treatments for nerve agent poisoning and other life-threatening conditions are about to become a...
By Mr. Frank Rando, CBRNE Protective & Biomedical Countermeasures SME, University of Arizona and Ms. Dee Ruelas, Clinical Specialist in COVID-19 testing and vaccination...
By Dave Mendez, Sheriff Deputy, King County, USA
As the King County Law Enforcement representative (Emergency Support Function 13), the County that the City of Seattle...
By Prof. Otakar Jiří Mika, Associate Professor, Police Academy Prague, Faculty of Security Management and Department of Crisis Management, Czech Republic.
A discussion on the...
By Ms. Elena Formicone, Analyst, IB Consultancy, Netherlands.
Security Overview
Despite its domestic political instability Peru managed to establish itself before the breakout of Covid-19 pandemic...
